Illumina, Inc.
ILU.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.77B
Close$
$80.68
35.1% downside
Current Fair Value
35.1% downsideOvervalued by 35.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.77 Billion |
|---|---|
| Enterprise Value | $20.17 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.48 |
| Beta | 1.47 |
| Outstanding Shares | 151,000,000 |
Return
| Return on Equity | 29.07% |
|---|---|
| Return on Assets | 12.41% |
| Return on Invested Capital | 18.71% |
Valuation & Multiples
| P/E Ratio | 51.42 |
|---|---|
| PEG | -431.54 |
| Price to Sales | 4.29 |
| Price to Book Ratio | 6.9 |
| Enterprise Value to Revenue | 4.49 |
| Enterprise Value to EBIT | 21.26 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Illumina Inc
8,600 employees
CEO: Francis deSouza Illumina, Inc. specializes in delivering advanced sequencing and array technologies designed for genetic and genomic examination. These offerings cater to a diverse array of markets, fostering the widespread use of genomic insights acros...